Anderson Kenneth Carl — SEC Form 4 filings
SEC reporting owner CIK 1824862. 14 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-04-02 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | Director | 14 | — | — | 15 |
Form 4 filings — Anderson Kenneth Carl
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 2,650 @ $4.34 | EDGAR |
| 2026-06-26 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 62,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | C4 Therapeutics, Inc. (CCCC) | Option exercise (M): 1,070 @ $2.11 · Option exercise (M): 1,070 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 4,259 @ $2.70 | EDGAR |
| 2026-01-05 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 5,958 @ $1.93 | EDGAR |
| 2025-10-03 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 5,349 @ $2.15 | EDGAR |
| 2025-07-02 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 7,616 @ $1.51 | EDGAR |
| 2025-06-20 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 35,500 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 7,841 @ $1.44 | EDGAR |
| 2025-01-03 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 3,074 @ $3.66 | EDGAR |
| 2024-10-02 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 2,023 @ $5.56 | EDGAR |
| 2024-07-02 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 2,320 @ $4.85 | EDGAR |
| 2024-06-21 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 32,500 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | C4 Therapeutics, Inc. (CCCC) | Grant/award (A): 1,389 @ $8.10 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1824862 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →